Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain Morphological Changes with Secukinumab in Psoriasis
NCT04717466Phase 4Completed
- Sponsor
- University of Miami
- Start
- Jun 2021
- Primary completion
- May 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of secukinumab in psoriasis, sponsored by University of Miami. Started Jun 2021; status: completed.
02
Drugs
secukinumab
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT04717466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04717466.